93 | 0 | 15 |
下载次数 | 被引频次 | 阅读次数 |
目的 分析贵州省习水县30~80岁居民高血压、高血糖、高血脂(简称“三高”)共病现状及影响因素,为制定“三高共管”综合干预措施提供科学依据。方法 2023年3月—7月,根据多阶段分层整群随机抽样原则,随机抽取贵州省习水县4个乡镇(街道)的16个行政村(居委会)30~80岁居民1 613人为调查对象,进行问卷调查、体格测量和实验室检测,采用二分类Logistic回归分析探讨“三高”共病发生的主要影响因素。结果 贵州省习水县30~80岁居民高血压、高血糖、高血脂患病率分别为47.6%、15.6%、43.5%,“三高”共病的患病率为7.3%。二分类Logistic回归分析显示,高年龄段(与30~44岁相比,45~59岁OR=3.597,95%CI:1.273~10.164;60~80岁OR=6.145,95%CI:2.150~17.562)、超重(OR=2.409,95%CI:1.354~4.285)、肥胖(OR=2.934,95%CI:1.514~5.689)、中心性肥胖(OR=3.004,95%CI:1.754~5.145)、有糖尿病家族史(OR=2.864,95%CI:1.238~6.625)是“三高”共病的危险因素。结论 贵州省习水县30~80岁居民高血压、高血糖、高血脂及“三高”共病的患病率较高,应将45岁及以上、超重、肥胖、中心性肥胖及有糖尿病家族史的居民作为“三高共管”的重点人群。
Abstract:Objective To analyze the current status and influencing factors of comorbidity involving hypertension, hyperglycemia, and hyperlipidemia(collectively referred to as "three-highs") among residents aged 30~80 in Xishui County, Guizhou Province, and to provide a scientific basis for the development of integrated intervention strategies for the management of these chronic conditions.Methods From March to July 2023,a total of 1,613 residents aged 30~80 were selected using multistage stratified cluster random sampling from 16 administrative villages(or neighborhood committees) across four townships(or subdistricts) in Xishui County.Data were collected through questionnaires, physical examinations, and laboratory tests.Binary logistic regression was employed to identify key risk factors associated with the comorbidity of the three-highs.Results The prevalence rates of hypertension, hyperglycemia, and hyperlipidemia among the participants were 47.6%,15.6%,and 43.5%,respectively.The prevalence of three-highs comorbidity was 7.3%.Binary logistic regression analysis revealed that older age(compared to 30~44 years: 45~59 years, OR=3.597,95% CI:1.273~10.164; 60~80 years, OR=6.145,95% CI:2.150~17.562),overweight status(OR=2.409,95% CI:1.354~4.285),obesity(OR=2.934,95% CI:1.514~5.689),central obesity(OR=3.004,95% CI:1.754~5.145),and a family history of diabetes(OR=2.864,95% CI:1.238~6.625) were significant risk factors for comorbidity.Conclusion The prevalence of hypertension, hyperglycemia, hyperlipidemia, and their comorbidity is relatively high among residents aged 30~80 in Xishui County.Residents aged 45 and above, those who are overweight or obese, have central obesity, or a family history of diabetes should be prioritized for integrated “three-highs” chronic disease management interventions.
[1] 中华人民共和国国家卫生健康委员会.中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521.
[2] VISSEREN FLJ,MACH F,SMULDERS YM,et al.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice[J].Eur Heart J,2021,42(34):3227-3337.
[3] 王梅杰,周翔,李亚杰,等.2010-2019年中国中老年人慢性病共病患病率的Meta分析[J].中国全科医学,2021,24(16):2085-2091.
[4] LIN HD,LI Q,HU Y,et al.The prevalence of multiple non-communicable diseases among middle-aged and elderly people:the Shanghai Changfeng Study[J].Eur J Epidemiol,2017,32(2):159-163.
[5] JAMSHED D,PRAVEEN C,RAJEEV C,et al.Clinical and demographic characteristics of patients with coexistent hypertension,type 2 diabetes mellitus,and dyslipidemia:a retrospective study from India [J].Drugs-Real World Outcomes,2024,11:167-176.
[6] 于宁,张梅,张笑,等.中国中老年居民高血压、糖尿病和血脂异常共病现状及影响因素研究[J].中华流行病学杂志,2023,44(2):196-204.
[7] CHEW NWS,NG CH,TAN DJH,et al.The global burden of metabolic disease:Data from 2000 to 2019 [J].Cell Metab,2023,35(3):414-428.
[8] 中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等.中国高血压防治指南(2018 年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[9] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版) (上)[J].中国实用内科杂志,2021,41(8):668-695.
[10] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
[11] 中华人民共和国国家卫生和计划生育委员会.成人体重判定:WS/T 428-2013[S].北京:中国标准出版社,2013.
[12] 杨继,张垚,马腾,等.1990-2019年中国心血管疾病流行现状、疾病负担及发病预测分析[J].中国全科医学,2024,27(2):233-244.
[13] 梁栋,杨成琳,林晓茹,等.1990-2019年中国成年人归因于糖尿病的心血管疾病负担研究[J].中国全科医学,2024,27(11):1380- 1386.
[14] 王增武.推进“三高”共管,全面防控心血管病[J].心脑血管病防治,2023,23(2):1-2.
[15] 丁贤彬,唐文革,陈莉玲,等.重庆市30~79岁居民高血压、高血脂、高血糖共病情况及相关影响因素[J].中国慢性病预防与控制,2023,31(1):31-34.
[16] 吴梦怡,胡劲松,黄霜,等.湖南省30岁及以上社区居民高血压、糖尿病、高血脂共病的影响因素分析[J].预防医学,2021,33(2):157-161.
[17] 韩胜红,张佩君,李俊琳,等.湖北省35~75岁居民高血压、糖尿病、高血脂患病及共病影响因素分析[J].应用预防医学,2019,25(5):356-360.
[18] LIN Q,WEIHUA W,RINA S,et al.Prevalence and risk factors of hypertension,diabetes,and dyslipidemia among adults in northwest China[J].International Journal of Hypertension,2021,5528007.
[19] 王维华,飒日娜,邱琳,等.陕西省成年居民慢性病及其危险因素分析[J].中华流行病学志,2019,40(12):1585-1589.
[20] 黄飞,朱进华,华召来,等.40~69岁居民肥胖类型与心血管危险因素的关联分析[J].现代预防医学,2023,50(13):2305-2310.
[21] TOMOKOY,MAKI KK,KAZUHIKO S,et al.Obesity and risk for its comorbidities diabetes,hypertension,and dyslipidemia in Japanese individuals aged 65 years[J].Scientific Reports,2023,13(1):2346.
[22] VEKIC J,ZELJKOVIC A,STEFANOVIC A,et al.Obesity and dyslipidemia [J].Metabolism,2019,92:71-81.
[23] DEMARCO VG,AROOR AR,SOWERS JR.The pathophysiology of hypertension in patients with obesity[J].Nat Rev Endocrinol,2014,10(6):364-376.
[24] 余成,王敏珍,靳亚飞,等.家族史和肥胖交互作用对糖尿病前期人群糖尿病发病的影响[J].中华疾病控制杂志,2020,24(9):997-1002.
基本信息:
DOI:
中图分类号:R544.1;R587.1;R589.2
引用信息:
[1]吴冬梅,张晓琴,余鳖等.贵州省习水县30~80岁居民高血压、高血糖、高血脂共病现状及影响因素分析[J].微量元素与健康研究,2025,42(04):43-47.
基金信息: